Viewpoint

Genomic Newborn Screening—A Long Road From Pilot to Public Policy

JAMA Pediatrics 10.1001/jamapediatrics.2025.3639

October 06, 2025 at 11:00 AM EDT

Read the full article

This Viewpoint discusses the advancement of genomic newborn screening and explores its potential to expand the population-based detection of treatable disorders in newborns.

Corresponding Author: François Boemer, PharmD, PhD, Biochemical Genetics Laboratory, Department of Human Genetics, CHU Sart-Tilman, University of Liege, B35, Liege 4000, Belgium (f.boemer@chuliege.be).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2025.3639?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100625

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks